Skip to content

Drug Name Identification an Ignored Patient's Problem That Needs a Solution

Drug Name Identification an Ignored Patient's Problem That Needs a Solution

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05343234
Enrollment
500
Registered
2022-04-25
Start date
2022-04-01
Completion date
2022-06-30
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Remember the Name of a Given Drug

Brief summary

Each of the recruited patient was given 3 different placebo drugs with 3 different mad up names to be taken for one month with different regiments. The drug name resembled a real drug but with enough difference to prevent the patient from trying to buy it as a safety precaution. The name was printed on the box in English and Arabic letters. The coloured shape was printed to 2x2 cm dimension. After one month the participants were intervened by a doctor blinded to the study. The doctor asked about the drug history of the patient. If the participant could remember the drug name and its correct regiment the doctor documented that. if the patent failed to remember the correct name and its regiment then the doctor asked the patient to try and remember anything about the drug. Then the patient would be asked about the symbol on the drug and was it helpful for him in any way.

Detailed description

A scoring system was used to evaluate pateints memory of the drugs used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly. The same scoring system was used for the symbols

Interventions

DRUGPlacebo

tree different placebo drugs with tree different names and scheduled will be given

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* ASA I and II patients

Exclusion criteria

* severe or life-threatening condition * severe visual impairment * mental or cognitive dysfunction

Design outcomes

Primary

MeasureTime frameDescription
score for remembering the drug namememory will be tested after one month from prescribing the drugsA scoring system was used to evaluate patients memory of the drugs name used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the patient could remember the name of the tree drugs correctly.
score for remembering the drug symbolmemory will be tested after one month from prescribing the drugsA scoring system was used to evaluate patients memory of the drugs symbol used 0- 3 0 is the minimal score and will be given if no recall of any drug symbol and 3 is the maximum score and will be given if the patient could remember the symbol of the tree drugs correctly.

Countries

Egypt

Contacts

Primary Contactyasser M osman
yasseralx@hotmail.com+201006357996
Backup Contactnouran t abdelsalam
yasser.osman@alexmed.edu.eg+201060122230

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026